TrialEuropean urology2018

Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).

Niven Mehra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.